NCT03808558: An ongoing trial by David E Gerber
This trial is ongoing. It must report results 3 months, 2 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT03808558 |
|---|---|
| Title | A Phase 2 Multi-center Pharmacodynamics Study of TVB-2640 in KRAS Mutant Non-small Cell Lung Carcinomas |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Sept. 11, 2019 |
| Completion date | April 3, 2025 |
| Required reporting date | April 3, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |